Showing results (251-260 of 302) with videos related to

Sort By:
Pageof 31
Expert Opinion on Investigational Drugs|June 20, 2020
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitorsFortunato Morabito, Massimo Gentile, Paola Monti, et al.
European Journal of Haematology|November 26, 2009
Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMAFortunato Morabito, Massimo Gentile, Stefania Ciolli, et al.
European Journal of Haematology|April 24, 2026
Regional Standardization of CLL Management: Results of a Delphi Consensus ProcessEnrica Antonia Martino, Annalisa Chiarenza, Salvatrice Mancuso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2017
High <i>BCR-ABL/GUS</i> Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose ImatinibPaolo Vigneri, Fabio Stagno, Stefania Stella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parametersMassimo Negrini, Giovanna Cutrona, Cristian Bassi, et al.
Pageof 31